BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 21944129)

  • 1. Role of inflammatory related gene expression in clear cell renal cell carcinoma development and clinical outcomes.
    Tan W; Hildebrandt MA; Pu X; Huang M; Lin J; Matin SF; Tamboli P; Wood CG; Wu X
    J Urol; 2011 Nov; 186(5):2071-7. PubMed ID: 21944129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression in clear cell renal cell carcinoma identified by gene expression profiling.
    Lane BR; Li J; Zhou M; Babineau D; Faber P; Novick AC; Williams BR
    J Urol; 2009 Feb; 181(2):849-60. PubMed ID: 19095258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic and prognostic value of CEP55 in clear cell renal cell carcinoma as determined by bioinformatics analysis.
    Zhou L; Liu S; Li X; Yin M; Li S; Long H
    Mol Med Rep; 2019 May; 19(5):3485-3496. PubMed ID: 30896867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and prognostic significance of a comprehensive epithelial-mesenchymal transition gene set in renal cell carcinoma.
    Chen D; Gassenmaier M; Maruschke M; Riesenberg R; Pohla H; Stief CG; Zimmermann W; Buchner A
    J Urol; 2014 Feb; 191(2):479-86. PubMed ID: 24012533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microarray gene expression profiling and analysis in renal cell carcinoma.
    Liou LS; Shi T; Duan ZH; Sadhukhan P; Der SD; Novick AA; Hissong J; Skacel M; Almasan A; DiDonato JA
    BMC Urol; 2004 Jun; 4():9. PubMed ID: 15212686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A three-gene expression signature model to predict clinical outcome of clear cell renal carcinoma.
    Yao M; Huang Y; Shioi K; Hattori K; Murakami T; Sano F; Baba M; Kondo K; Nakaigawa N; Kishida T; Nagashima Y; Yamada-Okabe H; Kubota Y
    Int J Cancer; 2008 Sep; 123(5):1126-32. PubMed ID: 18546273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Genes Involved in Cellular Adhesion and Extracellular Matrix Remodeling Correlates with Poor Survival of Patients with Renal Cancer.
    Boguslawska J; Kedzierska H; Poplawski P; Rybicka B; Tanski Z; Piekielko-Witkowska A
    J Urol; 2016 Jun; 195(6):1892-902. PubMed ID: 26631499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher programmed cell death 1 ligand 1 (PD-L1) mRNA level in clear cell renal cell carcinomas is associated with a favorable outcome due to the active immune responses in tumor tissues.
    Ning XH; Gong YQ; He SM; Li T; Wang JY; Peng SH; Chen JC; Liu JY; Qi NN; Guo YL; Gong K
    Oncotarget; 2017 Jan; 8(2):3355-3363. PubMed ID: 27926518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression profile of renal cell carcinoma clear cell type.
    Dall'Oglio MF; Coelho RF; Leite KR; Sousa-Canavez JM; Oliveira PS; Srougi M
    Int Braz J Urol; 2010; 36(4):410-8; discussion 418-9. PubMed ID: 20815947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clear Cell Renal Cell Carcinoma Subtypes Identified by BAP1 and PBRM1 Expression.
    Joseph RW; Kapur P; Serie DJ; Parasramka M; Ho TH; Cheville JC; Frenkel E; Parker AS; Brugarolas J
    J Urol; 2016 Jan; 195(1):180-7. PubMed ID: 26300218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoter hypermethylation profile of kidney cancer with new proapoptotic p53 target genes and clinical implications.
    Christoph F; Weikert S; Kempkensteffen C; Krause H; Schostak M; Köllermann J; Miller K; Schrader M
    Clin Cancer Res; 2006 Sep; 12(17):5040-6. PubMed ID: 16951219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinome expression profiling identifies IKBKE as a predictor of overall survival in clear cell renal cell carcinoma patients.
    Hildebrandt MA; Tan W; Tamboli P; Huang M; Ye Y; Lin J; Lee JS; Wood CG; Wu X
    Carcinogenesis; 2012 Apr; 33(4):799-803. PubMed ID: 22266464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNAs expression signatures of renal clear cell carcinoma revealed by microarray.
    Yu G; Yao W; Wang J; Ma X; Xiao W; Li H; Xia D; Yang Y; Deng K; Xiao H; Wang B; Guo X; Guan W; Hu Z; Bai Y; Xu H; Liu J; Zhang X; Ye Z
    PLoS One; 2012; 7(8):e42377. PubMed ID: 22879955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel prognostic model based on immunogenomics for clear cell renal cell carcinoma.
    Wu Z; Shen Y; Fan D; Liu J; Chen D; Wang K; Xu X
    Int Immunopharmacol; 2021 Jan; 90():107119. PubMed ID: 33243605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic biomarkers for renal cell carcinoma: selection using novel bioinformatics systems for microarray data analysis.
    Osunkoya AO; Yin-Goen Q; Phan JH; Moffitt RA; Stokes TH; Wang MD; Young AN
    Hum Pathol; 2009 Dec; 40(12):1671-8. PubMed ID: 19695674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DKC1 serves as a potential prognostic biomarker for human clear cell renal cell carcinoma and promotes its proliferation, migration and invasion via the NF‑κB pathway.
    Zhang M; Pan Y; Jiang R; Hou P; Shan H; Chen F; Jiang T; Bai J; Zheng J
    Oncol Rep; 2018 Aug; 40(2):968-978. PubMed ID: 29901172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleobindin 2 expression is an independent prognostic factor for clear cell renal cell carcinoma.
    Qi C; Ma H; Zhang HT; Gao JD; Xu Y
    Histopathology; 2015 Apr; 66(5):650-7. PubMed ID: 25322808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased Expression of Androgen Receptor mRNA in Human Renal Cell Carcinoma Cells is Associated with Poor Prognosis in Patients with Localized Renal Cell Carcinoma.
    Ha YS; Lee GT; Modi P; Kwon YS; Ahn H; Kim WJ; Kim IY
    J Urol; 2015 Nov; 194(5):1441-8. PubMed ID: 25796113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD31, EDNRB and TSPAN7 are promising prognostic markers in clear-cell renal cell carcinoma revealed by genome-wide expression analyses of primary tumors and metastases.
    Wuttig D; Zastrow S; Füssel S; Toma MI; Meinhardt M; Kalman K; Junker K; Sanjmyatav J; Boll K; Hackermüller J; Rolle A; Grimm MO; Wirth MP
    Int J Cancer; 2012 Sep; 131(5):E693-704. PubMed ID: 22213152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation.
    White NM; Bao TT; Grigull J; Youssef YM; Girgis A; Diamandis M; Fatoohi E; Metias M; Honey RJ; Stewart R; Pace KT; Bjarnason GA; Yousef GM
    J Urol; 2011 Sep; 186(3):1077-83. PubMed ID: 21784468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.